- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01287702
Early Feeding Following Ligation of Acute Bleeding Varices
The Impact of Early Feeding Following Ligation of the Acute Bleeding Varices
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Acute esophageal variceal hemorrhage is a dreadful complication of portal hypertension. Its management evolved rapidly in recent years. Traditional managements include vasoconstrictor and balloon tamponade. Vasoconstrictors have been shown to control approximately 80% of bleeding episodes, are generally used as a first line therapy. Following the use of vasoconstrictor, endoscopic therapy is often employed to arrest the bleeding varices as well as preventing early rebleeding. Meta-analysis showed that the combination of vasoconstrictor and endoscopic therapy is superior to endoscopic therapy alone in the control of acute esophageal variceal hemorrhage. Our previous study showed that endoscopic variceal ligation (EVL) is superior to Endoscopic injection sclerotherapy (EIS) in the control of active variceal hemorrhage. It is thus recommended that EVL is the first enscopic treatment of choice for acute esophageal variceal bleeding. Moreover, apart from the control of acute variceal bleeding, prophylactic antibiotics has been proven to be helpful in the prevention of bacterial infection as well as preventing early variceal bleeding. With the advent of new treatment modalities and measures taken to approach patients with acute esophageal variceal bleeding, the mortality of acute esophageal variceal bleeding is significantly reduced in recent years.
On the other hand, early rebleeding due to ligation-induced ulcer may be encountered. The impact of feeding after endoscopic treatment of gastroesophageal varices has never been investigated. It is still unknown whether early feeding may increase early rebleeding in patients with acute esophageal variceal bleeding treated with EVL. It is customary for clinicians to institute fasting for 2 or 3 days after emergency EVL. This may be a safe approach to watch against early rebleeding. However, many patients would be fasting for a longer time and nutrition may be impaired, possibly resulting in aggravation of ascites. Thus, we conduct a controlled study to evaluate whether early feeding have a bad impact on patients receiving emergency EVL or histoacryl injection for bleeding gastric varices.
Methods of treatment:
Enrolled Criteria:
- The etiology of portal hypertension is cirrhosis.
- Age ranges between 20-80 y/o.
- Patients presenting with acute gastroesophageal variceal bleeding proven by emergency endoscopy within 12 hours. (Acute esophageal variceal bleeding was defined as: 1) when blood was directly seen by endoscopy to issue from an esophageal varix (active bleeding), or 2) when patients presented with red color signs on their esophageal varices with blood in esophagus or stomach and no other potential site of bleeding identified (inactive bleeding). Gastric variceal bleeding is defined as active spurting from a gastric varix or presence of red spots on a gastric varix.
- EVL is performed after confirmation of acute esophageal variceal bleeding. Histoacryl injection is performed if acute gastric variceal bleeding is diagnosed. Bleeding is arrested on the spot.
Exclusion criteria:
1) association with severe systemic illness, such as sepsis, COPD, uremia, HCC, > BCLC stage B 3)failure in the control of bleeding by emergency endoscopic treatment. 4)moribund patients, died within 12 hours of enrollment 5)Uncooperative 6) Ever received EIS, EVL within one month prior to index bleeding 7)Child-Pugh's scores > 13 8) Deep jaundice (serum bilirubin > 10 mg/dl), presence of encephalopathy > stage II or massive ascites
Eligible subjects will receive vasoconstrictor for 3 days (either terlipressin or somatostatin), prophylactic antibiotics for 5 days (cephazolin or norfloxacin 400mg bid), lactulose. Eligible subjects will be randomized to 2 groups. Group 1 will be allowed to take liquid diet (fruit juice, soy bean juice, milk, rice in liquid form) for 3 days within 4 hours after endoscopic treatment. Additionally, intravenous fluid less than 500 cc per day will be given. Subsequently, soft diet will be given for 4 days, and on regular diet on the 8th day after endoscopic treatment.
Group 2 will be fasting for 48 hours after endoscopic treatment and intravenous fluids (normal saline or glucose water) 1500 cc per day with electrolytes will be administered for 2 days. After 2 days of fasting, if rebleeding does not occur, liquid diet will be given for one day, subsequently, soft diet for 4 days, and on regular diet on the 8th day after endoscopic treatment.
Study Type
Enrollment (Anticipated)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Kaohsiung, Taiwan, 824
- Recruiting
- E-DA Hospital
-
Contact:
- Gin Ho Lo, MD
- Phone Number: 0975106248
- Email: ghlo@kimo.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- The etiology of portal hypertension is cirrhosis.
- Age ranges between 20-80 y/o.
- Patients presenting with acute gastroesophageal variceal bleeding proven by emergency endoscopy within 12 hours. (Acute esophageal variceal bleeding was defined as: 1) when blood was directly seen by endoscopy to issue from an esophageal varix (active bleeding), or 2) when patients presented with red color signs on their esophageal varices with blood in esophagus or stomach and no other potential site of bleeding identified (inactive bleeding). Gastric variceal bleeding is defined as active spurting from a gastric varix or presence of red spots on a gastric varix.
- EVL is performed after confirmation of acute esophageal variceal bleeding. Histoacryl injection is performed if acute gastric variceal bleeding is diagnosed. Bleeding is arrested on the spot.
Exclusion Criteria:
- association with severe systemic illness, such as sepsis, COPD, uremia, HCC, > BCLC stage B
- failure in the control of bleeding by emergency endoscopic treatment.
- moribund patients, died within 12 hours of enrollment
- Uncooperative
- Ever received EIS, EVL within one month prior to index bleeding
- Child-Pugh's scores > 13
- Deep jaundice (serum bilirubin > 10 mg/dl), presence of encephalopathy > stage II or massive ascites
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Early feeding
patients receiving EVL will receive liquid diet since 4 hours after arresting of variceal bleedingpatients with acute bleeding varices arrested by EVL
|
patients receiving EVL will receive liquid diet since 4 hours after arresting of variceal bleedingpatients with acute bleeding varices arrested by EVL
|
Active Comparator: Dealyed feeding
patients with acute bleeding varices arrested by EVL, will receive feeding 48 hours after EVL.
|
patients with acute bleeding varices arrested by EVL, will receive feeding 48 hours after EVL
patients with acute bleeding varices arrested by EVL, will receive feeding 48 hours after EVL
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Success rate of initial hemostasis
Time Frame: 48 hours
|
hemostasis for 48 hours after ligation
|
48 hours
|
very early rebleeding rate
Time Frame: 48- 120 hours
|
rebleeding during this period
|
48- 120 hours
|
ulcer bleeding rate
Time Frame: 14 days
|
14 days after ligation of varices
|
14 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The amount of blood transfuion and mortality
Time Frame: 14 days
|
The amount of blood transfuion and mortality with 14 days
|
14 days
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- early feeding after ligation
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Varices
-
Ruijin HospitalRecruiting
-
Unity Health TorontoWithdrawnEndoscopic Ultrasound | Gastric Varices Bleeding
-
National Science Council, TaiwanE-DA HospitalUnknownUlcer, on Gastric Varices | Rebleeding From Gastric VaricesTaiwan
-
Assiut UniversityNot yet recruitingGastroesophageal Varices Hemorrhage
-
Mayo ClinicCompletedPortal Hypertension | Esophageal Varices | Gastric Varices
-
Shanghai Zhongshan HospitalUnknownLiver Cirrhosis | Gastroesophageal Varices
-
Institute of Liver and Biliary Sciences, IndiaNot yet recruitingHigh Risk Esophageal VaricesIndia
-
Institute of Liver and Biliary Sciences, IndiaWithdrawn
-
Asian Institute of Gastroenterology, IndiaRecruitingGastric Varices BleedingIndia
-
Indiana UniversityCompleted
Clinical Trials on Early feeding
-
Saint Thomas Hospital, PanamaCompletedComplications; Cesarean SectionPanama
-
University of Ghana Medical SchoolUnknownCesarean Section ComplicationsGhana
-
DHQ mardanDHQ HOSPITAL MARDANCompleted
-
All India Institute of Medical Sciences, New DelhiMaulana Azad Medical College; Sir Ganga Ram Hospital; Vardhman Mahavir Medical... and other collaboratorsCompletedPrematurity of Fetus | Postnatal Growth DisorderIndia
-
Acibadem UniversityCompletedPostoperative Nausea and Vomiting | Patient Satisfaction | Feeding Patterns | Cesarean DeliveryTurkey
-
The Catholic University of KoreaCompleted
-
National Taiwan University HospitalEnrolling by invitation
-
Icahn School of Medicine at Mount SinaiRecruitingHead and Neck Cancer | Free Tissue TransferUnited States
-
Lady Hardinge Medical CollegeAll India Institute of Medical Sciences, New DelhiCompletedTime for Achievement of Full Feeds
-
Shaare Zedek Medical CenterCompleted